DT
HealthMore in Health→
Researchers test a new approach to severe stimulant-related agitation
Key Takeaways
- A Marshall University preclinical study tested a dexmedetomidine-ketamine approach for methamphetamine-induced agitation.
- The combination nearly completely controlled agitation in rats and showed less intense side effects than high-dose dexmedetomidine.
- Researchers say dexmedetomidine is appealing because it does not impair breathing, even when opioids are present.
- The work reflects growing clinical pressure from polysubstance overdose cases.
DE
DT Editorial Team··via medicalxpress.com